Literature DB >> 885991

Gynecomastia and semen abnormalities induced by spironolactone in normal men.

R Caminos-Torres, L Ma, P J Snyder.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 885991     DOI: 10.1210/jcem-45-2-255

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  12 in total

Review 1.  Chemistry and structural biology of androgen receptor.

Authors:  Wenqing Gao; Casey E Bohl; James T Dalton
Journal:  Chem Rev       Date:  2005-09       Impact factor: 60.622

Review 2.  Adverse effects of common medications on male fertility.

Authors:  Mary K Samplaski; Ajay K Nangia
Journal:  Nat Rev Urol       Date:  2015-06-23       Impact factor: 14.432

Review 3.  Hirsutism and the effectiveness of spironolactone in its management.

Authors:  G R McMullen; A J Van Herle
Journal:  J Endocrinol Invest       Date:  1993-12       Impact factor: 4.256

Review 4.  Sexual dysfunction and male infertility.

Authors:  Francesco Lotti; Mario Maggi
Journal:  Nat Rev Urol       Date:  2018-03-13       Impact factor: 14.432

Review 5.  FDA-approved drugs that are spermatotoxic in animals and the utility of animal testing for human risk prediction.

Authors:  Elizabeth R Rayburn; Liang Gao; Jiayi Ding; Hongxia Ding; Jun Shao; Haibo Li
Journal:  J Assist Reprod Genet       Date:  2017-10-24       Impact factor: 3.412

6.  The effects of spironolactone on testosterone fractions and sex-hormone binding globulin binding capacity in hirsute women.

Authors:  J A Marcondes; S L Minanni; W W Luthold; A C Lerário; M Nery; B B Mendonça; B L Wajchenberg; M A Kirschner
Journal:  J Endocrinol Invest       Date:  1995-06       Impact factor: 4.256

7.  Administration of gonadal steroids to the castrated male rat prevents a decrease in the release of gonadotropin-releasing hormone from the incubated hypothalamus.

Authors:  R S Rudenstein; H Bigdeli; M H McDonald; P J Snyder
Journal:  J Clin Invest       Date:  1979-02       Impact factor: 14.808

8.  Sex hormone suppression and sexual impotence in hypoxic pulmonary fibrosis.

Authors:  P D Semple; G H Beastall; T M Brown; K W Stirling; R J Mills; W S Watson
Journal:  Thorax       Date:  1984-01       Impact factor: 9.139

9.  Lack of endocrine systemic side effects after topical application of spironolactone in man.

Authors:  F O Rey; C Valterio; L Locatelli; A A Ramelet; J P Felber
Journal:  J Endocrinol Invest       Date:  1988-04       Impact factor: 4.256

10.  Antiandrogenic properties of spironolactone. Clinical trial in the management of female hirsutism.

Authors:  M Messina; C Manieri; P Biffignandi; C Massucchetti; R F Novi; G M Molinatti
Journal:  J Endocrinol Invest       Date:  1983-02       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.